MEMPHASYS LIMITED. - Announcements

Market Cap $13.00M Add to my watchlist

Memphasys Limited is an Australia-based reproductive biotechnology company. The Company... Memphasys Limited is an Australia-based reproductive biotechnology company. The Company is engaged in developing medical devices, diagnostics, and media with application to assisted reproductive technology (ART) in humans and animals. The Company's product pipeline includes Felix, RoXsta, and AI-Port. Its advanced product, the Felix System, is a patented automated device for quickly and gently separating sperm from a semen sample for use in ART procedures. The Felix device consists of two main components: a console, which supplies electrical power, and a sterile disposable cartridge for sperm isolation and selection. RoXsta is an in-vitro diagnostic device that assesses semen and other bodily fluids for oxidative stress load. RoXsta also has an application as part of a suite of products that can support the animal industry. AI-Port has been developed for the purpose of maintaining the viability of livestock semen for up to seven days at a temperature range of 22 - 25 degrees Celsius.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

MEM	Rights issue completion and allotment		28/03/19		Share
MEM	Rights Issue Prospectus shortfall	PRICE SENSITIVE	26/03/19		Share
MEM	Appendix 3B - Rights Issue Prospectus		01/03/19		Share
MEM	Rights Issue Prospectus	PRICE SENSITIVE	01/03/19		Share
MEM	Half Yearly Report and Accounts	PRICE SENSITIVE	28/02/19		Share
MEM	Entitlement issue and dual listing	PRICE SENSITIVE	27/02/19		Share
MEM	Trading Halt	PRICE SENSITIVE	25/02/19		Share
MEM	FELIX product development and commercialisation update		29/01/19		Share
MEM	Expiry of unlisted options		18/01/19		Share
MEM	A FURTHER TWO KEY OPINION LEADERS APPOINTED		14/01/19		Share
MEM	TWO MORE KEY OPINION LEADERS APPOINTED		11/01/19		Share
MEM	First USA based KOL appointed to undertake FELIX assessment		20/12/18		Share
MEM	Cleansing Notice		03/12/18		Share
MEM	Appendix 3B		03/12/18		Share
MEM	2018 AGM - Results of Meeting		22/11/18		Share
MEM	2018 AGM Chairman's Address to Shareholders		22/11/18		Share
MEM	Second KOL appointed to undertake FELIX assessment		22/11/18		Share
MEM	MEM presentation to the TechInvest Conference		30/10/18		Share
MEM	Response to ASX aware query	PRICE SENSITIVE	23/10/18		Share
MEM	First KOL appointed to undertake FELIX assessment		22/10/18		Share
MEM	Response to ASX price query	PRICE SENSITIVE	18/10/18		Share
MEM	Pause in trading	PRICE SENSITIVE	18/10/18		Share
MEM	2018 Notice of Annual General Meeting/Proxy Form		11/10/18		Share
MEM	Change in substantial holding - AG		05/10/18		Share
MEM	Change in substantial holding - AC		05/10/18		Share
MEM	Change of Director's Interest Notice		02/10/18		Share
MEM	Change of Director's Interest Notice		02/10/18		Share
MEM	Change of Director's Interest Notice		27/09/18		Share
MEM	Change of Director's Interest Notice - MM		21/09/18		Share
MEM	Collaborative Agreement with Monash IVF Group	PRICE SENSITIVE	18/09/18		Share
MEM	Felix Development & Commercialisation Update		12/09/18		Share
MEM	Appendix 3B - options		06/09/18		Share
MEM	Appendix 4G and corporate governance statement		30/08/18		Share
MEM	Full Year Statutory Accounts		27/08/18		Share
MEM	Preliminary Final Report	PRICE SENSITIVE	24/08/18		Share
MEM	Consolidation update and correction to options		16/08/18		Share
MEM	Memphasys secures R&D tax refund for FELIX device developmnt		16/08/18		Share
MEM	Change in substantial holding - Peeters Investments		14/08/18		Share
MEM	Consolidation of securities and Form 3A.3		14/08/18		Share
MEM	Placement cleansing statement		09/08/18		Share
MEM	Appendix 3B		09/08/18		Share
MEM	Consolidation timetable update		07/08/18		Share
MEM	Results of Meeting of Shareholders		06/08/18		Share
MEM	Preeminent IVF clinics to conduct in-vitro studies on Felix		19/07/18	223.52KB	Share
MEM	Initial Director's Interest Notice		13/07/18	118.13KB	Share
MEM	Notice of General Meeting/Proxy Form		06/07/18	243.9KB	Share
MEM	Proposed share consolidaiton	PRICE SENSITIVE	03/07/18	156.25KB	Share
MEM	Non-executive Director Appointment and Resignation		07/06/18	259.92KB	Share
MEM	Becoming a substantial holder - Peters Investments		01/06/18	463.28KB	Share
MEM	Share Placement Cleansing Notice		25/05/18	159.44KB	Share
MEM	Appendix 3B - Peters Investments strategic investment		25/05/18	354.5KB	Share
MEM	Memphasys raises $1m via a strategic investment	PRICE SENSITIVE	25/05/18	243.14KB	Share
MEM	Felix device development update	PRICE SENSITIVE	03/05/18		Share
MEM	Settlement of legal dispute with Platinum Rd / Bridge Rd		19/03/18		Share
MEM	Correction to Placement Offer Cleansing Notice		14/03/18		Share
MEM	Appendix 3B (correction to 1 March 2018)		06/03/18		Share
MEM	Cleansing Notice		01/03/18		Share
MEM	Appendix 3B		01/03/18		Share
MEM	Appendix 4D - December 2017 Half year Financial Accounts	PRICE SENSITIVE	23/02/18		Share
MEM	Commercialisation Progress of Felix Device		22/02/18		Share
MEM	Legal action with Platinum Road / Bridge Road Capital	PRICE SENSITIVE	13/02/18		Share
MEM	Placement s708 cleansing notice		02/01/18		Share
MEM	Appendix 3B		02/01/18		Share
MEM	Change of Director's Interest Notice		29/12/17		Share
MEM	Becoming a substantial holder		29/12/17		Share
MEM	Change of Director's Interest Notice		29/12/17		Share
MEM	Change in substantial holding		29/12/17		Share
MEM	Placement Offer cleansing statement		29/12/17		Share
MEM	Appendix 3B Placement		29/12/17		Share
MEM	$400,000 Special Grant received from the NSW Medical Devices	PRICE SENSITIVE	22/12/17		Share
MEM	Results of General Meeting		21/12/17		Share
MEM	Non-Renounceable Rights Issue - Shortfall Shares		19/12/17		Share
MEM	Non-Renounceable Pro-rata Entitlement Offer despatched		08/12/17		Share
MEM	2017 Results of Annual General Meeting		05/12/17		Share
MEM	Chairman's Address to Shareholders		05/12/17		Share
MEM	Change of Director's Interest Notice		29/11/17		Share
MEM	Change in substantial holding		29/11/17		Share
MEM	Appendix 3B - Non-Renounceable Rights Issue		28/11/17		Share
MEM	MEM Non-Renounceable Rights Issue Offer	PRICE SENSITIVE	28/11/17		Share
MEM	Rights Offer Cleaning Notice	PRICE SENSITIVE	28/11/17		Share
MEM	$400,000 special grant offer from NSW Medical Devices Fund	PRICE SENSITIVE	24/11/17		Share
MEM	Share issue price for capital raising		22/11/17		Share
MEM	Notice of General Meeting/Proxy Form		22/11/17		Share
MEM	$3.75M Capital Raising to Accelerate Dev of Felix Device	PRICE SENSITIVE	21/11/17		Share
MEM	Annual Report to shareholders		01/11/17		Share
MEM	Notice of Annual General Meeting/Proxy Form		01/11/17		Share
MEM	Advanced development of Felix device supported by R&D rebate	PRICE SENSITIVE	10/10/17		Share
MEM	App4G and Corporate Governance Statement		29/09/17		Share
MEM	Full Year Statutory Accounts		29/09/17		Share
MEM	MEM completes PrIME and Manukan settlement action		27/09/17		Share
MEM	Adjusting amendment to Appendix 4E	PRICE SENSITIVE	13/09/17		Share
MEM	Memphasys settles dispute with Transocean Securities		08/09/17		Share
MEM	Appendix 4E Preliminary Final Report	PRICE SENSITIVE	31/08/17		Share
MEM	Memphasys Presentation - update on activities		07/08/17		Share
MEM	Correction to Outcome of Litigation	PRICE SENSITIVE	28/07/17		Share
MEM	Outcome of Litigation	PRICE SENSITIVE	27/07/17		Share
MEM	Trading Halt	PRICE SENSITIVE	25/07/17		Share
MEM	Cleansing Statement		17/07/17		Share
MEM	Appendix 3B		17/07/17		Share
MEM	Felix Project development update	PRICE SENSITIVE	13/07/17		Share

MEM Rights issue completion and allotment
28/03/19			Share
MEM Rights Issue Prospectus shortfall
26/03/19	PRICE SENSITIVE		Share
MEM Appendix 3B - Rights Issue Prospectus
01/03/19			Share
MEM Rights Issue Prospectus
01/03/19	PRICE SENSITIVE		Share
MEM Half Yearly Report and Accounts
28/02/19	PRICE SENSITIVE		Share
MEM Entitlement issue and dual listing
27/02/19	PRICE SENSITIVE		Share
MEM Trading Halt
25/02/19	PRICE SENSITIVE		Share
MEM FELIX product development and commercialisation update
29/01/19			Share
MEM Expiry of unlisted options
18/01/19			Share
MEM A FURTHER TWO KEY OPINION LEADERS APPOINTED
14/01/19			Share
MEM TWO MORE KEY OPINION LEADERS APPOINTED
11/01/19			Share
MEM First USA based KOL appointed to undertake FELIX assessment
20/12/18			Share
MEM Cleansing Notice
03/12/18			Share
MEM Appendix 3B
03/12/18			Share
MEM 2018 AGM - Results of Meeting
22/11/18			Share
MEM 2018 AGM Chairman's Address to Shareholders
22/11/18			Share
MEM Second KOL appointed to undertake FELIX assessment
22/11/18			Share
MEM MEM presentation to the TechInvest Conference
30/10/18			Share
MEM Response to ASX aware query
23/10/18	PRICE SENSITIVE		Share
MEM First KOL appointed to undertake FELIX assessment
22/10/18			Share
MEM Response to ASX price query
18/10/18	PRICE SENSITIVE		Share
MEM Pause in trading
18/10/18	PRICE SENSITIVE		Share
MEM 2018 Notice of Annual General Meeting/Proxy Form
11/10/18			Share
MEM Change in substantial holding - AG
05/10/18			Share
MEM Change in substantial holding - AC
05/10/18			Share
MEM Change of Director's Interest Notice
02/10/18			Share
MEM Change of Director's Interest Notice
02/10/18			Share
MEM Change of Director's Interest Notice
27/09/18			Share
MEM Change of Director's Interest Notice - MM
21/09/18			Share
MEM Collaborative Agreement with Monash IVF Group
18/09/18	PRICE SENSITIVE		Share
MEM Felix Development & Commercialisation Update
12/09/18			Share
MEM Appendix 3B - options
06/09/18			Share
MEM Appendix 4G and corporate governance statement
30/08/18			Share
MEM Full Year Statutory Accounts
27/08/18			Share
MEM Preliminary Final Report
24/08/18	PRICE SENSITIVE		Share
MEM Consolidation update and correction to options
16/08/18			Share
MEM Memphasys secures R&D tax refund for FELIX device developmnt
16/08/18			Share
MEM Change in substantial holding - Peeters Investments
14/08/18			Share
MEM Consolidation of securities and Form 3A.3
14/08/18			Share
MEM Placement cleansing statement
09/08/18			Share
MEM Appendix 3B
09/08/18			Share
MEM Consolidation timetable update
07/08/18			Share
MEM Results of Meeting of Shareholders
06/08/18			Share
MEM Preeminent IVF clinics to conduct in-vitro studies on Felix
19/07/18		223.52KB	Share
MEM Initial Director's Interest Notice
13/07/18		118.13KB	Share
MEM Notice of General Meeting/Proxy Form
06/07/18		243.9KB	Share
MEM Proposed share consolidaiton
03/07/18	PRICE SENSITIVE	156.25KB	Share
MEM Non-executive Director Appointment and Resignation
07/06/18		259.92KB	Share
MEM Becoming a substantial holder - Peters Investments
01/06/18		463.28KB	Share
MEM Share Placement Cleansing Notice
25/05/18		159.44KB	Share
MEM Appendix 3B - Peters Investments strategic investment
25/05/18		354.5KB	Share
MEM Memphasys raises $1m via a strategic investment
25/05/18	PRICE SENSITIVE	243.14KB	Share
MEM Felix device development update
03/05/18	PRICE SENSITIVE		Share
MEM Settlement of legal dispute with Platinum Rd / Bridge Rd
19/03/18			Share
MEM Correction to Placement Offer Cleansing Notice
14/03/18			Share
MEM Appendix 3B (correction to 1 March 2018)
06/03/18			Share
MEM Cleansing Notice
01/03/18			Share
MEM Appendix 3B
01/03/18			Share
MEM Appendix 4D - December 2017 Half year Financial Accounts
23/02/18	PRICE SENSITIVE		Share
MEM Commercialisation Progress of Felix Device
22/02/18			Share
MEM Legal action with Platinum Road / Bridge Road Capital
13/02/18	PRICE SENSITIVE		Share
MEM Placement s708 cleansing notice
02/01/18			Share
MEM Appendix 3B
02/01/18			Share
MEM Change of Director's Interest Notice
29/12/17			Share
MEM Becoming a substantial holder
29/12/17			Share
MEM Change of Director's Interest Notice
29/12/17			Share
MEM Change in substantial holding
29/12/17			Share
MEM Placement Offer cleansing statement
29/12/17			Share
MEM Appendix 3B Placement
29/12/17			Share
MEM $400,000 Special Grant received from the NSW Medical Devices
22/12/17	PRICE SENSITIVE		Share
MEM Results of General Meeting
21/12/17			Share
MEM Non-Renounceable Rights Issue - Shortfall Shares
19/12/17			Share
MEM Non-Renounceable Pro-rata Entitlement Offer despatched
08/12/17			Share
MEM 2017 Results of Annual General Meeting
05/12/17			Share
MEM Chairman's Address to Shareholders
05/12/17			Share
MEM Change of Director's Interest Notice
29/11/17			Share
MEM Change in substantial holding
29/11/17			Share
MEM Appendix 3B - Non-Renounceable Rights Issue
28/11/17			Share
MEM MEM Non-Renounceable Rights Issue Offer
28/11/17	PRICE SENSITIVE		Share
MEM Rights Offer Cleaning Notice
28/11/17	PRICE SENSITIVE		Share
MEM $400,000 special grant offer from NSW Medical Devices Fund
24/11/17	PRICE SENSITIVE		Share
MEM Share issue price for capital raising
22/11/17			Share
MEM Notice of General Meeting/Proxy Form
22/11/17			Share
MEM $3.75M Capital Raising to Accelerate Dev of Felix Device
21/11/17	PRICE SENSITIVE		Share
MEM Annual Report to shareholders
01/11/17			Share
MEM Notice of Annual General Meeting/Proxy Form
01/11/17			Share
MEM Advanced development of Felix device supported by R&D rebate
10/10/17	PRICE SENSITIVE		Share
MEM App4G and Corporate Governance Statement
29/09/17			Share
MEM Full Year Statutory Accounts
29/09/17			Share
MEM MEM completes PrIME and Manukan settlement action
27/09/17			Share
MEM Adjusting amendment to Appendix 4E
13/09/17	PRICE SENSITIVE		Share
MEM Memphasys settles dispute with Transocean Securities
08/09/17			Share
MEM Appendix 4E Preliminary Final Report
31/08/17	PRICE SENSITIVE		Share
MEM Memphasys Presentation - update on activities
07/08/17			Share
MEM Correction to Outcome of Litigation
28/07/17	PRICE SENSITIVE		Share
MEM Outcome of Litigation
27/07/17	PRICE SENSITIVE		Share
MEM Trading Halt
25/07/17	PRICE SENSITIVE		Share
MEM Cleansing Statement
17/07/17			Share
MEM Appendix 3B
17/07/17			Share
MEM Felix Project development update
13/07/17	PRICE SENSITIVE		Share

REFRESH

1 2 3 4 5 6

(20min delay)
Last 0.5¢		Change 0.000(0.00%)		Mkt cap ! $13.00M

Open	High	Low	Value	Volume
0.5¢	0.5¢	0.5¢	$935	187K

Buyers (Bids)

No.	Vol.	Price($)
6	5639600	0.5¢

Sellers (Offers)

Price($)	Vol.	No.
0.6¢	11066843	9

View Market Depth

No.	Vol.	Price($)
2	60206	0.024
1	14090	0.022
3	497619	0.021
5	649700	0.020
2	130000	0.018

Price($)	Vol.	No.
0.025	153799	6
0.037	18526	1
0.039	1200000	1
0.046	100000	1
0.047	1160000	3

Last trade - 11.48am 28/11/2024 (20 minute delay)

MEM (ASX) Chart